89371-37-9 (咪达普利,Imidapril)

咪达普利;依达普利;(-)-(4S)-3-[(2S)-2[(1S)-1-乙氧羰基-3-苯丙基]氨基丙酰基]-1-甲基-2-氧代咪唑啉-4-羧酸;咪达普利-D5;稀禾定;盐酸咪达普利;(4S)-3-[(2S)-2-[N-[(1S)-1-(乙氧羰基)-3-苯丙基]氨基]丙酰基]-1-甲基-2-氧代咪唑烷-4-羧酸;咪唑普利;

Imidapril;(S)-3-(N-((S)-1-Ethoxycarbonyl-3-phenylpropyl)-L-alanyl)-1-methyl-2-oxoimidazoline-4-carboxylic acid;Imidapril Hydrochloride;(4S)-3-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-1-methyl-2-oxoimidazolidine-4-carboxylic acid;Imidapril HCl;(4S)-1-methyl-3-{(2S)-2-[N-(1S)-1-ethoxycarbonyl-3-phenylpropyl)amino]propionyl}-2-oxoimidazolidine-4-carboxylic acid;(4S)-3-<(2S)-2-<N-<(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl>amino>propionyl>-1-methyl-2-oxoimidazolidine-4-carboxylic Acid;Hipertene (TN);Imidapril (INN);Imidapril [BAN:INN];Imidaprilum;(4S)-3-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1-methyl-2-oxo-4-imidazolidinecarboxylic acid (ACI);4-Imidazolidinecarboxylic acid, 3-[2-[[1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]-1-methyl-2-oxo-, [4S-[3[R*(R*)],4R*]]- (ZCI);NS00007217;(4S)-3-((2S)-2-(((2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino)propanoyl)-1-methyl-2-oxoimidazolidine-4-carboxylic acid;DTXCID3028217;BDBM50020400;NCGC00181342-03;(4S)-3-{N-[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]-L-alanyl}-1-methyl-2-oxoimidazolidine-4-carboxylic acid;DB11783;AC-25844;(4S)-3-(N-((2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)-L-alanyl)-1-methyl-2-oxoimidazolidine-4-carboxylic acid;Imidaprilum [INN-Latin];NCGC00181342-05;NCGC00181342-01;IMIDAPRIL [MI];Novaloc;(4S)-3-[(2S)-2-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]-1-methyl-2-oxoimidazolidine-4-carboxylic acid;(4S)-1-methyl-3-((2S)-2-(N-((1S)-1-ethoxycarbonyl-3-phenylpropyl)amino)propionyl)-2-oxo-imidazolidine-4-carboxylic acid;SCHEMBL34098;GTPL6377;HY-B1451A;CHEMBL317094;MFCD00923828;AB01565810_02;(S)-3-((S)-2-((S)-1-ethoxy-1-oxo-4-phenylbutan-2-ylamino)propanoyl)-1-methyl-2-oxoimidazolidine-4-carboxylic acid;Hipertene;IMIDAPRIL [WHO-DD];Tanatril (TN);(4S)-1-methyl-3-[(2S)-2-[N-((1S)-1-ethoxycarbonyl-3-phenylpropyl)amino]propionyl]-2-oxo-imidazolidine-4-carboxylic acid;AKOS015967028;CHEBI:135654;Q1041804;1-((S)-2-((S)-1-ethoxy-1-oxo-4-phenylbutan-2-ylamino)propanoyl)-3-methyl-2-oxo-2,3-dihydro-1H-imidazole-5-carboxylic acid;Tanapril;UNII-BW7H1TJS22;1-methyl-3-(2-(N-(1-ethoxycarbonyl-3-phenylpropyl)amino)propionyl)-2-oxoimidazolidine-4-carboxylic acid;D08068;89371-37-9;C09AA16;IMIDAPRIL [INN];CS-0137517;BW7H1TJS22;3-[2-(1-Ethoxycarbonyl-3-phenyl-propylamino)-propionyl]-1-methyl-2-oxo-imidazolidine-4-carboxylic acid;DTXSID2048242;Tanatril;(S)-3-((S)-2-(((S)-1-Ethoxy-1-oxo-4-phenylbutan-2-yl)amino)propanoyl)-1-methyl-2-oxoimidazolidine-4-carboxylic acid;Imidaprilum (INN-Latin);TA 6366;Imidapril [INN:BAN];Q-102511;

KLZWOWYOHUKJIG-BPUTZDHNSA-N

1S/C20H27N3O6/c1-4-29-19(27)15(11-10-14-8-6-5-7-9-14)21-13(2)17(24)23-16(18(25)26)12-22(3)20(23)28/h5-9,13,15-16,21H,4,10-12H2,1-3H3,(H,25,26)/t13-,15-,16-/m0/s1

C(N1C(=O)N(C)C[C@H]1C(=O)O)(=O)[C@H](C)N[C@H](C(=O)OCC)CCC1C=CC=CC=1

血管紧张素转化酶抑制剂，前体药物，用于高血压。

在碳酸钾存在下，用α-溴代苯丁酸乙酯对丙氨酸苄酯进行N上的烷基化反应，再氢解脱去苄基，生成的游离酸用N-羟基琥珀酰亚胺酯化后，与咪唑啉酯在叔丁醇钾的叔丁醇溶液中反应，产物经水解，酸化得到盐酸咪达普利。另一制备方法为先用叔丁醇对3-苄氧羰基-2-氧咪唑啉-4-羧酸进行酯化，再用碘甲烷进行N上甲基化，氢解脱去3位上的苄氧羰基，使咪唑啉环上3位上的N游离，可以用α-对甲苯磺酰基丙酰氯对其进行酰化，酰化产物和α-氨基苯丁酸乙酯反应，得到咪达普利的叔丁酯产物，再经水解，酸化得盐酸咪达普利。